Skip to content

    Stoke Therapeutics (STOK) stock price & financials

    View STOK earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+63.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $4.89M
    $22.61M
    $158.57M
    $13.82M
    $10.63M
    +117.2%
    $1.40M
    -93.8%
    $6.23M
    -96.1%
    $9.32M
    -32.5%
    Weakening
    Operating Profit
    -$30.00M
    -$13.65M
    $111.24M
    -$27.30M
    -$43.09M
    -43.6%
    -$61.44M
    -349.9%
    -$53.42M
    -148.0%
    -$65.43M
    -139.7%
    Weakening
    Net Profit
    -$26.43M
    -$10.48M
    $112.88M
    -$23.48M
    -$38.35M
    -45.1%
    -$57.93M
    -452.7%
    -$50.00M
    -144.3%
    -$61.62M
    -162.4%
    Weakening
    EPS
    $-0.47
    $1.95
    $-0.40
    $-0.65
    -38.3%
    $-0.79
    -140.5%
    $-0.93
    -132.5%
    Weakening
    Other Income
    $3.57M
    $3.17M
    $2.92M
    $3.82M
    $3.47M
    -3.0%
    $3.50M
    +10.5%
    $3.42M
    +17.1%
    $3.81M
    -0.2%
    Strengthening
    Interest
    $0
    -$1.0K
    $1.0K
    $3.0K
    $3.0K
    $2.0K
    $23.0K
    +2200.0%
    $17.0K
    +466.7%
    Strengthening
    Depreciation
    Profit before Tax
    -$26.43M
    $114.16M
    -$23.48M
    -$39.63M
    -49.9%
    -$50.00M
    -143.8%
    -$61.62M
    -162.4%
    Weakening
    MarginsOPM
    -613.1%
    -60.4%
    70.2%
    -197.6%
    -405.3%
    +33.9%
    -4382.2%
    -7157.8%
    -857.6%
    -1322.5%
    -701.6%
    -255.1%
    Weakening
    Tax
    0.0%
    1.1%
    0.0%
    3.2%
    0.0%
    -100.0%
    0.0%
    Weakening
    ReturnsROIC
    4.3%
    1.7%
    -18.5%
    3.9%
    6.3%
    +45.1%
    9.5%
    +452.7%
    8.2%
    10.1%
    +162.4%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$105.40M$222.47M$287.31M$144.90M$113.56M$191.44M$127.98M$84.22M$110.00M
    Short-Term Investments
    Total Current Assets$106.14M$226.03M$293.93M$229.22M$244.07M$215.34M$232.76M$305.70M$322.54M
    Net PP&E$1.19M$2.51M$3.79M$9.08M$11.43M$12.43M$8.25M$6.25M$6.70M
    Goodwill
    Intangibles
    Total Assets$107.54M$228.75M$297.93M$238.87M$256.07M$228.34M$271.56M$418.43M$393.97M
    LiabilitiesTotal Current Liabilities$2.47M$4.10M$11.43M$17.14M$31.39M$30.82M$40.06M$57.88M$41.93M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$80.0K$3.53M$2.72M$4.77M$2.45M$1.14M$837.0K
    Total Liabilities$2.47M$4.32M$11.85M$21.09M$71.22M$68.78M$42.53M$65.98M$48.42M
    EquityCommon Stock & APIC$3.0K$4.0K$4.0K$4.0K$5.0K$5.0K$5.0K$6.0K
    Retained Earnings-$25.71M-$58.03M-$110.28M-$196.08M-$297.15M-$401.85M-$490.83M-$497.71M-$609.34M
    Total Equity$105.07M$224.43M$286.08M$217.78M$184.85M$159.56M$229.02M$352.46M$345.55M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$10.96M-$31.05M-$42.22M-$66.91M-$31.87M-$81.07M-$86.85M$45.59M-$177.99M
    Cash from Investing-$925.0K-$1.63M-$1.05M-$76.43M-$45.88M$105.95M-$107.47M-$186.81M$7.75M
    Cash from Financing$115.64M$149.76M$108.11M$1.28M$46.41M$53.01M$131.09M$97.39M$181.70M
    SummaryCapital Expenditure-$935.0K-$1.64M-$1.05M-$1.20M-$3.96M-$1.62M-$203.0K-$670.0K-$2.69M
    Free Cash Flow-$11.90M-$32.69M-$43.27M-$68.11M-$35.83M-$82.68M-$87.05M$44.91M-$180.68M
    FCF Margin-288.8%-941.7%-238.1%24.4%-654.9%

    Ratios